Maintenance of Efficacy of Lisdexamfetamine Dimesylate in Adults with Attention-Deficit/Hyperactivity Disorder: Randomized Withdrawal Design | June 2012

Abstracts

Journal of Clinical Psychiatry

http://dx.doi.org/10.4088/JCP.11m07430

A 12-Month Open-Label Extension Study of the Safety and Tolerability of Lisdexamfetamine Dimesylate for Major Depressive Disorder in Adults | August 2018

Articles

Journal of Clinical Psychopharmacology

https://journals.lww.com/psychopharmacology/Fulltext/2018/08000/A_12_Month_Open_Label_Extension_Study_of_the.10.aspx

Lisdexamfetamine Dimesylate: A Prodrug Stimulant for the Treatment of ADHD in Children and Adults | May 2010

Articles (Manuscripts-Versions)

Washington University in St.Louis>CNS Spectrums

https://digitalcommons.wustl.edu/open_access_pubs/3506/

Assessing Effects of Treatment with Lisdexamfetamine Dimesylate for Pediatric ADHD Using a Parental Survey | April 2010

Abstracts

CNS Spectrums

https://doi.org/10.1017/S1092852900000080

Effect of Lisdexamfetamine Dimesylate on Sleep in Adults with Attention-Deficit/Hyperactivity Disorder | August 2009

Articles

Behavioral and Brain Functions

https://behavioralandbrainfunctions.biomedcentral.com/articles/10.1186/1744-9081-5-34

Lisdexamfetamine Dimesylate in the Treatment of Attention-Deficit/Hyperactivity Disorder: Pharmacokinetics, Efficacy and Safety in Children and Adolescents | March 2014

Articles

Archives of Clinical Psychiatry

http://ref.scielo.org/7n9tfw

Efficacy and Safety of Lisdexamfetamine for Treatment of Adults with Moderate to Severe Binge-Eating Disorder: A Randomized Clinical Trial | March 2015

Articles

JAMA Psychiatry

https://jamanetwork.com/journals/jamapsychiatry/fullarticle/2089519

A Randomized Controlled Trial of the Efficacy and Safety of Lisdexamfetamine Dimesylate as Augmentation Therapy in Adults with Residual Symptoms of Major Depressive Disorder After Treatment with Escitalopram | August 2013

Abstracts

Journal of Clinical Psychiatry

http://dx.doi.org/10.4088/JCP.13m08360

Risk of Major Cardiovascular and Cerebrovascular Events in Users of Lisdexamfetamine and Other Medications for Attention-Deficit/Hyperactivity Disorder in Denmark and Sweden: A Population-Based Cohort Study | August 2022

Articles

Neurology and Therapy

https://link.springer.com/article/10.1007/s40120-022-00396-y

Lisdexamfetamine for the Treatment of Acute Methamphetamine Withdrawal: A Pilot Feasibility and Safety Trial | November 2022

Articles

Drug and Alcohol Dependence

https://www.sciencedirect.com/science/article/pii/S037687162200429X

Efficacy of Lisdexamfetamine Dimesylate in Children with Attention-Deficit/Hyperactivity Disorder Previously Treated with Methylphenidate: A Post Hoc Analysis | November 2011

Articles

Child and Adolescent Psychiatry and Mental Health

https://capmh.biomedcentral.com/articles/10.1186/1753-2000-5-35

Molecular Characterisation of the Mechanism of Action of Stimulant Drugs Lisdexamfetamine and Methylphenidate on ADHD Neurobiology: A Review | August 2022

Articles

Neurology and Therapy

https://link.springer.com/article/10.1007/s40120-022-00392-2

Post Hoc Analyses of the Impact of Previous Medication on the Efficacy of Lisdexamfetamine Dimesylate in the Treatment of Attention-Deficit/Hyperactivity Disorder in a Randomized, Controlled Trial | October 2014

Articles

Neuropsychiatric Disease and Treatment

https://doi.org/10.2147/NDT.S68273

Lisdexamfetamine Dimesylate in Binge Eating Disorder: A Placebo Controlled Trial | September 2016

Abstracts

Human Psychopharmacology: Clinical and Experimental

http://onlinelibrary.wiley.com/doi/10.1002/hup.2547/abstract

Executive Function Deficits in Children with Attention-Deficit/Hyperactivity Disorder and Improvement with Lisdexamfetamine Dimesylate in an Open-Label Study | December 2010

Articles

NCBI>Journal of Child and Adolescent Psychopharmacology

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3005278/

European, Randomized, Phase 3 Study of Lisdexamfetamine Dimesylate in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder | January 2013

Articles

European Neuropsychopharmacology

https://www.sciencedirect.com/science/article/pii/S0924977X12003240

Lisdexamfetamine Effects on Executive Activation and Neurochemistry in Menopausal Women with Executive Function Difficulties | September 2016

Articles

NCBI>Neuropsychopharmacology

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5399233/

Lisdexamfetamine Dimesylate for Adults with Moderate to Severe Binge Eating Disorder: Results of Two Pivotal Phase 3 Randomized Controlled Trials | October 2015

Articles

Neuropsychopharmacology

http://dx.doi.org/10.1038/npp.2015.275

Update on the Management of Attention-Deficit/Hyperactivity Disorder in Children and Adults: Patient Considerations and the Role of Lisdexamfetamine | December 2009

Articles

Therapeutics and Clinical Risk Management

https://doi.org/10.2147/TCRM.S6733

Lisdexamfetamine in the Treatment of Adolescents and Children with Attention-Deficit/Hyperactivity Disorder | May 2012

Articles

Adolescent Health, Medicine and Therapeutics

https://doi.org/10.2147/AHMT.S19815

Participant-Perceived Quality of Life in a Long-Term, Open-Label Trial of Lisdexamfetamine Dimesylate in Adolescents with Attention-Deficit/Hyperactivity Disorder | May 2014

Articles

NCBI>Journal of Child and Adolescent Psychopharmacology

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4026374/

Pilot Study of the Effects of Lisdexamfetamine on Cocaine Use: A Randomized, Double-Blind, Placebo-Controlled Trial | June 2015

Articles (Manuscripts-Versions)

PubMed Central>Drug and Alcohol Dependence

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4509923/

Cognitive Function of Children and Adolescents with Attention-Deficit/Hyperactivity Disorder in a 2-Year Open-Label Study of Lisdexamfetamine Dimesylate | January 2018

Articles

CNS Drugs

https://link.springer.com/article/10.1007/s40263-017-0487-z

Efficacy and Tolerability of Lisdexamfetamine Dimesylate in Children with Attention-Deficit/Hyperactivity Disorder: Sex and Age Effects and Effect Size Across the Day | December 2010

Articles

Child and Adolescent Psychiatry and Mental Health

https://capmh.biomedcentral.com/articles/10.1186/1753-2000-4-32

Attention Deficit Hyperactivity Disorder Subtypes and Symptom Response in Adults Treated with Lisdexamfetamine Dimesylate | May 2012

Articles

NCBI>Innovations in Clinical Neuroscience

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3398683/

Time Course of the Effects of Lisdexamfetamine Dimesylate in Two Phase 3, Randomized, Double-Blind, Placebo-Controlled Trials in Adults with Binge-Eating Disorder | May 2017

Articles

International Journal of Eating Disorders

https://onlinelibrary.wiley.com/doi/10.1002/eat.22722

Long-Term Study of Lisdexamfetamine Dimesylate in Japanese Children and Adolescents with Attention-Deficit/Hyperactivity Disorder | December 2019

Articles

Neuropsychopharmacology Reports

https://onlinelibrary.wiley.com/doi/full/10.1002/npr2.12091

Efficacy and Tolerability of Lisdexamfetamine as an Antidepressant Augmentation Strategy: A Meta-Analysis of Randomized Controlled Trials | October 2017

Abstracts

Journal of Affective Disorders

https://www.sciencedirect.com/science/article/pii/S0165032717302823

Clinical Characteristics and Treatment Response to Lisdexamfetamine Dimesylate versus Placebo in Adults with Binge Eating Disorder: Analysis by Gender and Age | March 2019

Abstracts

Journal of Clinical Psychiatry

https://doi.org/10.4088/JCP.18m12378

The Cost Effectiveness of Lisdexamfetamine Dimesylate for the Treatment of Binge Eating Disorder in the USA | February 2016

Articles

Clinical Drug Investigation

https://link.springer.com/article/10.1007/s40261-016-0381-3

The Use of Lisdexamfetamine to Treat ADHD in a Patient with Stimulant (Methamphetamine) Use Disorder | August 2023

Articles

Case Reports in Psychiatry

https://doi.org/10.1155/2023/5574677

Health-Related Quality of Life and Functional Outcomes from a Randomized-Withdrawal Study of Long-Term Lisdexamfetamine Dimesylate Treatment in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder | August 2014

Articles

CNS Drugs

https://link.springer.com/article/10.1007/s40263-014-0193-z

A Phase 3, Multicenter, Open-Label, 12-Month Extension Safety and Tolerability Trial of Lisdexamfetamine Dimesylate in Adults with Binge Eating Disorder | June 2017

Articles

Journal of Clinical Psychopharmacology

https://journals.lww.com/psychopharmacology/Fulltext/2017/06000/A_Phase_3,_Multicenter,_Open_Label,_12_Month.8.aspx

Update on Optimal Use of Lisdexamfetamine in the Treatment of ADHD | July 2013

Articles

Neuropsychiatric Disease and Treatment

https://www.dovepress.com/update-on-optimal-use-of-lisdexamfetamine-in-the-treatment-of-adhd-peer-reviewed-article-NDT

Efficacy of Lisdexamfetamine Dimesylate in Adults with Attention-Deficit/Hyperactivity Disorder Previously Treated with Amphetamines: Analyses from a Randomized, Double-Blind, Multicenter, Placebo-Controlled Titration Study | December 2012

Articles

BMC Pharmacology and Toxicology

https://bmcpharmacoltoxicol.biomedcentral.com/articles/10.1186/2050-6511-13-18

Review of Lisdexamfetamine Dimesylate in Adults with Attention-Deficit/Hyperactivity Disorder | August 2017

Articles

Journal of Central Nervous System Disease

http://dx.doi.org/10.1177/1179573517728090

Treatment Outcomes with Lisdexamfetamine Dimesylate in Children Who Have Attention-Deficit/Hyperactivity Disorder with Emotional Control Impairments | August 2013

Articles

NCBI>Journal of Child and Adolescent Psychopharmacology

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3749705/

Efficacy of Lisdexamfetamine Dimesylate throughout the Day in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: Results from a Randomized, Controlled Trial | May 2013

Articles

European Child and Adolescent Psychiatry

https://link.springer.com/article/10.1007/s00787-013-0421-y

Randomized, Double-Blind, Placebo-Controlled Acute Comparator Trials of Lisdexamfetamine and Extended-Release Methylphenidate in Adolescents with Attention-Deficit/Hyperactivity Disorder | October 2017

Articles

CNS Drugs

https://link.springer.com/article/10.1007/s40263-017-0468-2

Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Lisdexamfetamine Dimesylate in Adults with Attention-Deficit/Hyperactivity Disorder | September 2008

Abstracts

Journal of Clinical Psychiatry

https://doi.org/10.4088/jcp.v69n0903

Maintenance of Efficacy of Lisdexamfetamine Dimesylate in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: Randomized-Withdrawal Study Design | March 2014

Articles

Journal of the American Academy of Child and Adolescent Psychiatry

https://www.sciencedirect.com/science/article/pii/S0890856714001580

Lisdexamfetamine in the Treatment of Moderate-to-Severe Binge Eating Disorder in Adults: Systematic Review and Exploratory Meta-Analysis of Publicly Available Placebo-Controlled, Randomized Clinical Trials | July 2016

Articles

Neuropsychiatric Disease and Treatment

https://www.dovepress.com/lisdexamfetamine-in-the-treatment-of-moderate-to-severe-binge-eating-d-peer-reviewed-article-NDT

Lisdexamfetamine: A Review in Binge Eating Disorder | November 2017

Abstracts

CNS Drugs

https://link.springer.com/article/10.1007/s40263-017-0477-1

A Placebo-Controlled Trial of Lisdexamfetamine in the Treatment of Comorbid Sluggish Cognitive Tempo and Adult ADHD | June 2021

Abstracts

Journal of Clinical Psychiatry

https://doi.org/10.4088/JCP.20m13687

Efficacy and Safety of Lisdexamfetamine Dimesylate in Children with Attention-Deficit/Hyperactivity Disorder and Recent Methylphenidate Use | May 2013

Articles

Advances in Therapy

https://link.springer.com/article/10.1007/s12325-013-0027-2

Novel Pharmacologic Treatment in Acute Binge Eating Disorder: Role of Lisdexamfetamine | April 2016

Articles

Neuropsychiatric Disease and Treatment

https://doi.org/10.2147/NDT.S80881

A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of Lisdexamfetamine Dimesylate Augmentation for Major Depressive Disorder in Adults with Inadequate Response to Antidepressant Therapy | August 2017

Articles

Journal of Psychopharmacology

https://journals.sagepub.com/doi/10.1177/0269881117722998

Long-Acting Stimulants for Treatment of Attention-Deficit/Hyperactivity Disorder: A Focus on Extended-Release Formulations and the Prodrug Lisdexamfetamine Dimesylate to Address Continuing Clinical Challenges | April 2013

Articles

ADHD Attention Deficit and Hyperactivity Disorders

https://link.springer.com/article/10.1007/s12402-013-0106-x

Lisdexamfetamine Dimesylate Augmentation in Adults with Persistent Executive Dysfunction After Partial or Full Remission of Major Depressive Disorder | January 2014

Articles

NCBI>Neuropsychopharmacology

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3988542/

Prediction of Placebo Response in 2 Clinical Trials of Lisdexamfetamine Dimesylate for the Treatment of ADHD | February 2011

Abstracts

Journal of Clinical Psychiatry

https://doi.org/10.4088/jcp.10m05979pur